Silence Therapeutics PLC(SLN) - 2023 Q4 - Earnings Call Transcript

Silence Therapeutics plc (NASDAQ:SLN) Q4 2023 Earnings Conference March 13, 2024 8:00 AM ET Company Participants Gem Hopkins - Head of Investor Relations & Corporate Communications Craig Tooman - President & Chief Executive Officer Rhonda Hellums - Chief Financial Officer Steven Romano - Head of R&D Conference Call Participants Mike Ulz - Morgan Stanley Kostas Biliouris - BMO Capital Markets Patrick Trucchio - H.C. Wainwright Keay Nakae - Chardan Research Operator Good day, and thank you for standing by. We ...